Ubs Group Ag Nexgel, Inc. Call Options Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NXGL
# of Institutions
14Shares Held
233KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA56.8KShares$188,7080.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA50KShares$165,9170.0% of portfolio
-
Simon Quick Advisors, LLC35.7KShares$118,5730.01% of portfolio
-
Northeast Financial Group, Inc. Tannersville, PA31.8KShares$105,7350.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny28.5KShares$94,4700.0% of portfolio
About NEXGEL, INC.
- Ticker NXGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 5,572,230
- Market Cap $18.5M
- Description
- NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...